文献速递神经康复

卒中后早期康复剂量的安全性:日本全国医疗索赔数据的复合结局分析

Safety of Early Rehabilitation Dose After Stroke on Composite Outcomes: Analysis of Nationwide Japanese Medical Claims Data.
PubMed 文献 · Neurorehabil Neural Repair · 2026-07-27

本研究利用日本诊断程序组合数据库(2018-2022)在目标试验模拟框架下分析成人急性卒中患者住院2天内启动康复的安全性。结果显示较高早期康复剂量总体与较低院内不良事件发生率相关,60分钟/天尤其第1天启动者估计风险最低,但中等剂量方案结果不一。

要点

  • 较高早期康复剂量总体与较低院内不良事件发生率相关。
  • 60分钟/天尤其第1天启动的康复方案估计风险最低。
  • 中等剂量方案在不同分析情景中结果不一致,关联并非严格线性。

核心结论

  • 较高早期康复剂量总体与较低的院内不良事件累积发生率相关。
  • 60分钟/天尤其第1天启动的方案估计风险最低,但关联并非严格线性。

研究设计与样本

  • 目标试验模拟框架下分析日本诊断程序组合数据库(2018-2022)数据。
  • 纳入年龄≥18岁、因急性卒中入住急性医院并在入院2天内接受院内康复的患者。

主要发现

  • 参照方案下复合不良事件发生率为11.2%(95%CI:9.75%-12.60%)。
  • 最高发生率为26.20%(95%CI:24.30%-28.20%),相对参照的风险比(RR)为2.35(95%CI:2.03-2.72)。
  • 中等剂量方案在不同分析情景中关联结果不一。

关键数值与推荐

  • 康复暴露定义为6种预设方案(20-60分钟/天,第1天或第2天启动),持续至第14天。
  • 结局为入院后15天内复合不良事件的累积发生率。
  • 采用序贯双重稳健估计器与纵向改良治疗策略,处理时变暴露并减少时间相关偏倚。

临床怎么用

  • 在临床合适时,充分剂量的早期康复可能具有潜在获益。
  • 需重视患者选择与监测,尤其对中等剂量方案应个体化评估。

局限性

  • 中等剂量方案结果在不同分析情景中不一致,关联并非严格线性。
  • 研究基于医疗索赔数据的目标试验模拟,可能存在未测量混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Early rehabilitation guidelines lack a consensus on the optimal early rehabilitation regimen; hence, the impact of rehabilitation timing and dose on stroke recovery outcomes remains unclear. Using Japanese medical claims data within a target trial emulation framework, this study evaluated the safety of early in-hospital rehabilitation after stroke. PATIENTS AND METHODS: This study analyzed patients aged ≥ 18 years who were admitted to an acute hospital for acute stroke and received in-hospital rehabilitation within 2 days after admission, using the Japan Diagnosis Procedure Combination database (2018-2022). Rehabilitation exposures were defined as 6 predefined regimens (20-60 min/day initiated on days 1 or 2) and continued up to day 14. The outcome was the cumulative incidence of composite adverse events within 15 days after admission. A sequential, doubly robust estimator with a longitudinal modified treatment policy was applied, accounting for time-varying exposures and reducing potential time-related biases. RESULTS: Using a target trial emulation framework with doubly robust estimation, the incidence under the reference regimen was 11.2% (95% CI: 9.75%-12.60%). The highest incidence was 26.20% (95% CI: 24.30%-28.20%), corresponding to a risk ratio (RR) of 2.35 (95% CI: 2.03-2.72) compared with the reference. In contrast, several higher-intensity regimens were associated with lower incidences, with the lowest incidence of .49% (95% CI: .28%-.71%), yielding an RR of .04 (95% CI: .03-.07) versus the reference. However, intermediate-dose regimens showed variable associations across scenarios. DISCUSSION AND CONCLUSION: In this emulated trial, higher early rehabilitation doses were generally associated with a lower incidence of in-hospital adverse events. Regimens involving 60 min/day, particularly when initiated on day 1, showed the lowest estimated risk. However, the associations were not strictly linear, as intermediate-dose regimens demonstrated variable results across analyses. These findings suggest a potential benefit of adequately dosed early rehabilitation when clinically appropriate, while highlighting the importance of careful patient selection and monitoring.

来源:Neurorehabil Neural Repair,查看原文。版权归原作者所有。

引用

  1. Tani T, Cooray U, Nishida D, et al. Safety of Early Rehabilitation Dose After Stroke on Composite Outcomes: Analysis of Nationwide Japanese Medical Claims Data. Neurorehabil Neural Repair. 2026. PMID: 42504690. doi:10.1177/15459683261469074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。